Aung Tun

9PUBLICATIONS

49CO-AUTHORS

AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunology not elsewhere classifiedMedical parasitology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 20, 2026

Diffuse Large B-Cell Lymphoma Presenting in a Background of Rosai-Dorfman Disease.

|Apr 25, 2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Feb 24, 2026

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Dec 11, 2025

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Aug 11, 2025

CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.

Jordan Gauthier, Kwang W Ahn, Jinalben Patel

|Jun 05, 2024

Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study.

Aung M Tun, Romil D Patel, Frederique St-Pierre

Pageof 2

Frequent Collaborators

Yucai Wang

James R Cerhan

Reem Karmali

Christine E Ryan

Anita Kumar

Brad S Kahl

Priyanka A Pophali

Ashlee Joseph

Natalie S Grover

Steven R Hwang

Frequent Collaborators

Yucai Wang

James R Cerhan

Reem Karmali

Christine E Ryan